FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 48 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $108,000 | -20.6% | 19,500 | -33.5% | 0.00% | -33.3% |
| Q2 2017 | $136,000 | -73.4% | 29,340 | -71.6% | 0.01% | -76.9% |
| Q1 2017 | $511,000 | -96.6% | 103,290 | -92.4% | 0.03% | -96.6% |
| Q4 2016 | $14,995,000 | +19.9% | 1,350,847 | 0.0% | 0.77% | +11.8% |
| Q3 2016 | $12,509,000 | +45.8% | 1,350,847 | 0.0% | 0.69% | +41.9% |
| Q2 2016 | $8,578,000 | -2.6% | 1,350,847 | 0.0% | 0.48% | -8.0% |
| Q1 2016 | $8,808,000 | -19.6% | 1,350,847 | 0.0% | 0.53% | -24.5% |
| Q4 2015 | $10,955,000 | +10.6% | 1,350,847 | 0.0% | 0.70% | -5.5% |
| Q3 2015 | $9,902,000 | -14.8% | 1,350,847 | +19.2% | 0.74% | -16.2% |
| Q2 2015 | $11,617,000 | +208.5% | 1,133,390 | +178.4% | 0.88% | +189.2% |
| Q1 2015 | $3,766,000 | – | 407,121 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |